Applications of 4-Amino-2-Chloropyrimidine in Industrial Manufacturing

As a specialized manufacturer of 4-Amino-2-Chloropyrimidine, we support advanced chemical synthesis workflows across pharmaceutical, agrochemical, and material science fields. This intermediate serves as a core building block for complex molecular assemblies in regulated industrial environments, driving forward the development and commercial-scale production of leading-edge products.

1. Pharmaceutical API Intermediate Synthesis

Producers of active pharmaceutical ingredients (APIs) utilize this pyrimidine derivative as a targeted intermediate in small-molecule drug synthesis, especially in classes such as kinase inhibitors and antiviral therapies. Chemists value its position as a nucleophilic amine source and its reactivity in heterocyclic expansion steps, integrating it at precise stages to enable downstream functionalization under GMP settings. Operations maintain strict quality assurance through continuous monitoring from raw material intake to final API output.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• US FDA 21 CFR Part 210/211
• European Pharmacopoeia (Ph. Eur.) compliance for process impurities
• EDQM CEP submission for EU market APIs

Typical usage ratio

• Typically 0.1–0.3 molar equivalents per batch step; adjusted based on stoichiometry of the target heterocycle and impurity profile in process validation

Downstream process integration

• Incorporated in midstream coupling or cyclization—often after chlorination and prior to final derivatization/purification under cGMP batch or flow chemistry regimes

Final product types

• Oral and injectable oncology drug substances (small molecules)
• Antiviral and anti-infective APIs
• Investigational new chemical entities for clinical trials

2. Agrochemical Active Ingredient Manufacturing

In the crop protection sector, 4-Amino-2-Chloropyrimidine enables the construction of selective herbicidal, fungicidal, and pesticidal agents. Formulators use it as a core scaffold in the pyrimidine ring system, tailoring the substitution pattern to modulate bioactivity and environmental persistence. The reliability of supply and traceability from synthesis through to technical concentrate matter for both stewardship and product registration.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• OECD Principles of Good Laboratory Practice (GLP) during active development
• REACH registration for EU distribution
• ISO 9001 Quality Management Systems for traceability

Typical usage ratio

• Typically 5–10% by mass in the active ingredient synthesis; varies depending on end-use technical grade requirements and impurity controls

Downstream process integration

• Introduced in the initial nucleophilic substitution or amination stage of active ingredient manufacturing—generally before esterification or halogenation steps

Final product types

• Pre-emergence and post-emergence herbicide actives
• Seed treatment fungicide intermediates
• Miticide formulations

3. Dye and Pigment Intermediate Production

Manufacturers in the specialty dye sector utilize this compound as a precursor for functional dyes and colorants where pyrimidine motifs confer solubility and fastness. It uniquely supports azo and anthraquinone dye synthesis through its amino-chloro configuration, critical for color stability and consistent shade development, especially in textile and ink applications with demanding wash and light-resistance needs.

Industry compliance standards

• Oeko-Tex Standard 100 for textile applications
• ISO 105 Series (Textile Test Methods for Colour Fastness)
• REACH restrictions on aromatic amines (>0.1%)
• ZDHC Manufacturing Restricted Substances List for global brands

Typical usage ratio

• 6–12% by total mass in dye intermediate formulations; production engineers adjust concentration for hue intensity and downstream dispersibility

Downstream process integration

• Feeds into diazotization or nucleophilic substitution reactions to generate the core chromophore units prior to sulfonation or coupling steps

Final product types

• Reactive textile dyes (especially for cellulose and polyamide fibers)
• High-stability pigment dispersions for industrial inks
• Fluorescent dye markers for analytical use

4. Synthesis of Veterinary Drug Intermediates

Industrial veterinary drug API producers exploit the selective reactivity of this pyrimidine when constructing key ring systems in antimicrobial and antiparasitic compounds used in livestock. Quality-by-design principles require full process documentation at the intermediate stage, with traceable lot controls and analytical verification to satisfy VICH and local veterinary health authorities during dossier submissions.

Industry compliance standards

• VICH GL3 (Good Manufacturing Practice for APIs for Veterinary Medicinal Products)
• China Veterinary Pharmacopoeia compliance for registration
• US FDA Guidance for Industry #66—Production of Veterinary Drug Substances
• ISO 17025-accredited analytical monitoring during batch QC

Typical usage ratio

• Stoichiometric ratios between 0.2–0.5 equivalents, set by impurity thresholds and target molecule requirements for specific drug scaffolds

Downstream process integration

• Used at the cyclization or amination step region to assemble central heterocyclic rings, typically before acylation or further substitution

Final product types

• Oral and injectable veterinary antimicrobials (quaternary pyrimidine-based APIs)
• Antiparasitic agents for large-animal formulations
• Premix and feed additive drugs requiring stable intermediates

5. Seed Treatment Chemical Formulation

Seed coating and treatment producers apply pyrimidine building blocks for enhancement agents in both fungicidal and germination-boost products. The aminopyrimidine structure supports synthesis of seed-applied actives with low mammalian toxicity yet strong target specificity, meeting tight residue controls and stewardship protocols for modern agriculture.

Industry compliance standards

• OECD Guidelines for the Testing of Chemicals – Seed Treatment Products
• EPA 40 CFR Part 180 – Tolerance for Residues
• Global GAP for seed production supply chains
• ISO 17034 Reference Material Producer Accreditation for QC

Typical usage ratio

• Entry concentration 3–8% by mass in technical concentrate; altered according to specific seed crop and targeted application rate per hectare

Downstream process integration

• Blended into formulation processes after primary synthesis, entering granulation, coating, or pelleting operations based on final delivery form

Final product types

• Seed-coating fungicide active formulations
• Growth regulator seed dressings
• Microgranulated seed treatment products for cereals and legumes

6. Synthesis of DNA/RNA Base Analogues for Research

Research reagent and biotech supply companies choose aminopyrimidine derivatives as foundational substrates for constructing base analogues, probes, and molecular diagnostics reagents. The unique substitution pattern enables labeled nucleoside synthesis and site-selective modification, providing reliable reactivity for downstream conjugation chemistries that support genomics and synthetic biology R&D worldwide.

Industry compliance standards

• ISO 9001:2015 Quality Management for Life Science Suppliers
• ISO 13485 Medical Devices—Quality for Diagnostic Reagents
• OECD GLP for research batches
• USP Reference Standards for nucleoside analogues

Typical usage ratio

• Supplied at <1–5 g/L solution for nucleoside conjugation; batch size and concentration determined by final probe design and labeling protocol

Downstream process integration

• Used in stepwise organic synthesis to introduce modified bases—central in coupling reactions prior to sugar attachment or linker derivatization

Final product types

• Oligonucleotide probes and hybridization arrays
• Modified RNA/DNA building blocks for gene editing
• Fluorescently labeled nucleotides for sequencers